GAM
INFI

Griffin Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Griffin Asset Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-700
Closed -$1K – 496
2019
Q2 		$1K Buy
+700
New +$1.13K ﹤0.01% 554

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Griffin Asset Management's INFI Position: Q3 2019 in Review

Griffin Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2019, closing a stake of 700 shares — an estimated $1K sold.

Griffin Asset Management first reported a position in INFI in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 51 funds tracked by Wall St. Rank hold INFI as of Q3 2019.

  • Griffin Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Griffin Asset Management sold 700 Infinity Pharmaceuticals, Inc. shares in Q3 2019, an estimated $1K.
  • Griffin Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2019 and held it in 1 quarter.
  • Griffin Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $1K in Q2 2019.
  • 51 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2019.

Based on Griffin Asset Management's 13F filing for Q3 2019, filed 5 Nov 2019.